Phenylbutazone Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2025
Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) for the short-term treatment of fever and pain in animals. In the UK and the U.S., it is no longer approved for human use, as it can cause severe adverse effects such as aplastic anemia and suppression of white blood cell production. Phenylbutazone was originally used in humans for the treatment of gout and rheumatoid arthritis in 1949. Phenylbutazone is commonly used in horses for the following purposes: Antipyresis and Analgesia. Phenylbutazone is...
View full press release